182 related articles for article (PubMed ID: 8251314)
1. Serum and urine soluble interleukin-2 receptor in idiopathic nephrotic syndrome.
Bock GH; Ongkingco JR; Patterson LT; Ruley J; Schroepfer LR; Nelson DL
Pediatr Nephrol; 1993 Oct; 7(5):523-8. PubMed ID: 8251314
[TBL] [Abstract][Full Text] [Related]
2. [Changes in soluble interleukin-2 receptor and its significance in nephrotic syndrome].
Zhang DY; Ye RG; Li YJ
Zhonghua Nei Ke Za Zhi; 1994 May; 33(5):309-12. PubMed ID: 7835141
[TBL] [Abstract][Full Text] [Related]
3. [Interleukin-17 concentration in serum and urine of children with idiopathic nephrotic syndrome].
Kiliś-Pstrusińska K; Zwolińska D; Medyńska A; Wawro A; Kordecki H
Przegl Lek; 2006; 63 Suppl 3():198-200. PubMed ID: 16898529
[TBL] [Abstract][Full Text] [Related]
4. Soluble interleukin-2 receptor in patients with glomerular diseases.
Chen HS; Wu MS; Yen TS; Chen WY
Postgrad Med J; 1995 Oct; 71(840):617-22. PubMed ID: 8545291
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-18 in urine and serum of children with idiopathic nephrotic syndrome.
Kiliś-Pstrusińska K; Medyńska A; Zwolińska D; Wawro A
Kidney Blood Press Res; 2008; 31(2):122-6. PubMed ID: 18391570
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte release of soluble IL-2 receptors in patients with minimal change nephropathy.
Mandreoli M; Beltrandi E; Casadei-Maldini M; Mancini R; Zucchelli A; Zucchelli P
Clin Nephrol; 1992 Apr; 37(4):177-82. PubMed ID: 1582055
[TBL] [Abstract][Full Text] [Related]
7. T-lymphocyte populations, cytokines and other growth factors in serum and urine of children with idiopathic nephrotic syndrome.
Daniel V; Trautmann Y; Konrad M; Nayir A; Schärer K
Clin Nephrol; 1997 May; 47(5):289-97. PubMed ID: 9181275
[TBL] [Abstract][Full Text] [Related]
8. Decreased renal excretion of soluble interleukin-2 receptor alpha after treatment with daclizumab.
ter Meulen CG; Göertz JH; Klasen IS; Verweij CM; Hilbrands LB; Wetzels JF; Hoitsma AJ
Kidney Int; 2003 Aug; 64(2):697-703. PubMed ID: 12846768
[TBL] [Abstract][Full Text] [Related]
9. An assessment of serum and urine soluble interleukin-2 receptor concentrations during renal transplant rejection.
Bock GH; Neu L; Long C; Patterson LT; Korb S; Gelpi J; Nelson DL
Am J Kidney Dis; 1994 Mar; 23(3):421-6. PubMed ID: 8128944
[TBL] [Abstract][Full Text] [Related]
10. Impaired urinary excretion of soluble IL-2 receptors in patients with systemic lupus erythematosus and rheumatoid arthritis.
Manoussakis MN; Germanidis GS; Drosos AA; Moutsopoulos HM
Lupus; 1992 Feb; 1(2):105-9. PubMed ID: 1301961
[TBL] [Abstract][Full Text] [Related]
11. Elevated soluble CD8 antigen and soluble interleukin-2 receptors in the sera of patients with juvenile rheumatoid arthritis.
Lipnick RN; Sfikakis PP; Klipple GL; Tsokos GC
Clin Immunol Immunopathol; 1993 Jul; 68(1):64-7. PubMed ID: 8513595
[TBL] [Abstract][Full Text] [Related]
12. Lymphocyte subpopulations, interleukin-2 and interleukin-2 receptor expression in childhood nephrotic syndrome.
Hulton SA; Shah V; Byrne MR; Morgan G; Barratt TM; Dillon MJ
Pediatr Nephrol; 1994 Apr; 8(2):135-9. PubMed ID: 8018488
[TBL] [Abstract][Full Text] [Related]
13. Soluble interleukin-2 receptors in sera of children with primary malignant neoplasms.
Bodey B; Psenko V; Lipsey AL; Kaiser HE
Anticancer Res; 1996; 16(1):219-24. PubMed ID: 8615612
[TBL] [Abstract][Full Text] [Related]
14. Soluble interleukin-2 receptor levels and immune activation in patients with schistosomiasis and carcinoma of the urinary bladder.
Raziuddin S; Shetty S; Ibrahim A
Scand J Immunol; 1992 Jun; 35(6):637-41. PubMed ID: 1604238
[TBL] [Abstract][Full Text] [Related]
15. Serum concentration of the soluble interleukin-2 receptor in vitiligo patients.
Yeo UC; Yang YS; Park KB; Sung HT; Jung SY; Lee ES; Shin MH
J Dermatol Sci; 1999 Apr; 19(3):182-8. PubMed ID: 10215190
[TBL] [Abstract][Full Text] [Related]
16. Soluble interleukin-2 receptors in the serum of patients with chronic renal failure.
Takamatsu T; Yasuda N; Ohno T; Kanoh T; Uchino H; Fujisawa A
Tohoku J Exp Med; 1988 Aug; 155(4):343-7. PubMed ID: 3068834
[TBL] [Abstract][Full Text] [Related]
17. Determination of age-related changes in human soluble interleukin 2 receptor in body fluids of normal subjects as a control value against disease states.
Gotoh Y; Okamoto Y; Uemura O; Mori N; Tanaka S; Ando T; Nishida M
Clin Chim Acta; 1999 Nov; 289(1-2):89-97. PubMed ID: 10556656
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of serum levels of soluble interleukin-2 receptor in patients with localized scleroderma.
Ihn H; Sato S; Fujimoto M; Kikuchi K; Takehara K
Br J Dermatol; 1996 May; 134(5):843-7. PubMed ID: 8736323
[TBL] [Abstract][Full Text] [Related]
19. Soluble interleukin-2 receptor in juvenile rheumatoid arthritis.
Silverman ED; Laxer RM; Nelson DL; Rubin LA
J Rheumatol; 1991 Sep; 18(9):1398-402. PubMed ID: 1757944
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of soluble interleukin-2 receptor in patients with various renal diseases.
Sugimoto H; Hashimoto N; Suzuki S; Gejyo F
Tohoku J Exp Med; 1998 Apr; 184(4):311-6. PubMed ID: 9699247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
